| Groups |
BNP
[pg/ml] |
NT-proBNP
[pg/ml] |
ANP
[pg/ml] |
NT-proANP
[nmol/l] |
| AD-EDMD |
42 (18-54) *,# |
85 (17-195) * |
273 (1.3-366) |
0.50 (0.28-0.58) ## |
| X-EDMD |
24 (6-105) # |
53 (14-192) |
366 (0.9-391) |
0.54 (0.37-0.60) ## |
| X-EDMD carriers |
22 (9-62) |
87 (33-400) |
8.1 (0.9-8.1) |
0.34 (0.29-0.65) |
| Dystrophinopathies |
163 (50-337) *** |
103 (9-457) * |
344 (286-362) *** |
2.5 (1.6-2.6) *** |
| Healthy controls |
15 (9-20) |
29 (15-49) |
4.9 (2.3-5.6) |
0.38 (0.32-0.42) |
Medians and interquartile ranges are presented
* p<0.05, ** p<0.005, *** p<0.0005 for the patient groups vs. healthy controls
# p<0.05, ## p<0.005; AD-EDMD or X-EDMD patients vs. disease controls
|
